NEWS: FDA Approves First Fast-Acting Copycat Insulin, Sanofi's Admelog

As brand-name insulins that have dominated the market continue going off patent, new "generic" copy versions are poised to shake up the diabetes world.And now... Hello, generic meal-time insulin! On Dec. 11, the first short-acting insulin of this ...
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs